FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 06/25/2007 |
3. Issuer Name and Ticker or Trading Symbol
Oncologix Tech Inc. [ OCLG.OB ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Options (right to buy)(1) | 12/19/2006 | 12/19/2011 | Common Stock | 200,000 | $0.19 | D | |
Stock Options (right to buy)(2) | 03/22/2007 | 03/22/2013 | Common Stock | 100,000 | $0.4 | D | |
Stock Options (right to buy)(3) | (3) | 06/25/2017 | Common Stock | 20,000 | $0.38 | D | |
Stock Options (right to buy)(4) | 07/06/2008 | 07/06/2013 | Common Stock | 100,000 | $0.4 | D |
Explanation of Responses: |
1. These options were granted on 12-19-05 by our Company's Board of Directors. These options were granted at the fair market price of the Company's common stock on 12-19-05. |
2. These options were granted on 03-22-06 by our Company's Board of Directors. These options were granted at the fair market price of the Company's common stock on 03-22-06. |
3. In accordance with Mr. Kurtzman being elected to the Company's Board of Directors on June 25, 2007, and as part of the Company's 2000 Incentive Stock Plan, Mr. Kurtzman was granted 20,000 options to purchase the Company's Common Stock. These options vest as follows: 6,666 vest on June 25, 2007; 6,667 vest on June 25, 2008; 6,667 vest on June 25, 2009. These options shall terminate upon the first to occur, 90 days after termination or ten years after the grant dtae. These options were granted at their fair market value on the date of the grant. |
4. These options were granted on 07-06-07 by our Company's Board of Directors. These options were granted at the fair market price of the Company's common stock on 07-06-07. |
Steven Kurtzman | 07/13/2007 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |